Published in Cancer Weekly, November 2nd, 1998
Donor lymphocyte infusions (DLI) are an effective treatment for leukemia relapse after allogeneic bone marrow transplantation. Undesired side-effects are the development of graft-versus-host disease (GVHD) and the occurrence of pancytopenia in certain patients.
W. Siegert, Humboldt University, Germany, and colleagues performed a pilot study to explore the effect of unmanipulated granulocyte-colony stimulating factor (G-CSF)-mobilized stem cells in generating...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.